A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)

Clinical trial NCT02664558 · COMPLETED

Trial details

NCT number: NCT02664558
Sponsor: Eiger BioPharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pulmonary Arterial Hypertension

Start date: 2016-04-01
Primary completion: 2017-11-01
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.